Descrizione Clinica
Condronil IALQUATTRO
Description
Injectable sterile gel, biodegradable and isotonic, for intra-articular use. Condronil IALQUATTRO consists of a medium molecular weight hyaluronic acid, produced by Streptococcus equi bacteria, formulated at a concentration of 20 mg/ml in a physiological buffer. Condronil IALQUATTRO is characterized by viscoelastic properties, therefore it allows to favor the normalization of the viscosity of the synovial liquid present in the cavity intra-articular.
Replaced by the synovial liquid that, thanks to its viscoelastic and lubricants properties, promotes the restoration of the rheological conditions of the joints, altered in case of degenerative or post-traumatic affections. The product, improving the characteristics of the synovial fluid, exercises a protective action of the joints and promotes the improvement of the joint function and the reduction of the painful symptomatology. Condronil IALQUATTRO acts only at the level of the joint in which it is injected without exercising any systemic action.
Mode of use
Remove any joint deposit before injecting Condronil IALQUATTRO; for removal of the efffusion and injection of Condronil IALQUATTRO must be used the same needle. Remove the protective syringe cap paying special attention to avoid contact with opening. Securely screw the diameter needle between 18 and 22 G to the Luer type closing collar following the indications below. Before injection treat the site with a proper disinfectant.
Inject Condronil IALQUATTRO by adopting a septic technique. Inject only in the joint cavity.
It is recommended to carry out one or more treatment sessions according to the prescription.
A. Carefully unscrew the cap from the tip of the syringe, paying particular attention to avoid contact with the opening.
B. Gently grab the protection of the needle and mount the needle on the Luer-lock attack, screwing firmly until you feel a slight counterpression to ensure a stagnant seal and prevent the outflow of the gel during administration.
Components
Sodium hyaluronate (20 mg/ml), sodium chloride, sodium phosphate monobasic dihydrate, sodium phosphate bibasic dodecaidrate, water p.p.i.
Warnings
Indicated only for intra-arthic injections such as hip and knee and should be dispensed only by a doctor who received a specific training on the technique of intra-articular injections.
Before use check the integrity of the syringe and the expiry date. Do not use needles other than those indicated. The product must be injected in the presence of an infected or severely inflamed joint. Infiltration should be avoided in case of infections in place or inflammatory conditions of the skin near the infiltration site. Since clinical data on the use of hyaluronate in children are not available, treatment with Condonil IALQUATTRO in these cases is not recommended. It is recommended to recommend to the patient, after intra-articular injection, to avoid challenging physical activity for jointing and to resume normal activity after a couple of days.
Condronil IALQUATTRO is a disposable product, quality and sterility are guaranteed only if the syringe is sealed. Any residue must therefore be disposed of and not reused even after a new sterilization.
Do not use the product if the packaging is already open or damaged.
Keep out of reach of children.
The complete needle syringe must be eliminated immediately after use, although the solution has not been fully administered. After use delete according to the current rules.
Conservation
Store at 2-25 °C in a dry place in the original box. Protect from light, heat and frost.
Format
Pre-filled syringe containing 4 ml of apirogen gel, sterilized with wet heat.
Injectable sterile gel, biodegradable and isotonic, for intra-articular use. Condronil IALQUATTRO consists of a medium molecular weight hyaluronic acid, produced by Streptococcus equi bacteria, formulated at a concentration of 20 mg/ml in a physiological buffer. Condronil IALQUATTRO is characterized by viscoelastic properties, therefore it allows to favor the normalization of the viscosity of the synovial liquid present in the cavity intra-articular.
Replaced by the synovial liquid that, thanks to its viscoelastic and lubricants properties, promotes the restoration of the rheological conditions of the joints, altered in case of degenerative or post-traumatic affections. The product, improving the characteristics of the synovial fluid, exercises a protective action of the joints and promotes the improvement of the joint function and the reduction of the painful symptomatology. Condronil IALQUATTRO acts only at the level of the joint in which it is injected without exercising any systemic action.
Mode of use
Remove any joint deposit before injecting Condronil IALQUATTRO; for removal of the efffusion and injection of Condronil IALQUATTRO must be used the same needle. Remove the protective syringe cap paying special attention to avoid contact with opening. Securely screw the diameter needle between 18 and 22 G to the Luer type closing collar following the indications below. Before injection treat the site with a proper disinfectant.
Inject Condronil IALQUATTRO by adopting a septic technique. Inject only in the joint cavity.
It is recommended to carry out one or more treatment sessions according to the prescription.
A. Carefully unscrew the cap from the tip of the syringe, paying particular attention to avoid contact with the opening.
B. Gently grab the protection of the needle and mount the needle on the Luer-lock attack, screwing firmly until you feel a slight counterpression to ensure a stagnant seal and prevent the outflow of the gel during administration.
Components
Sodium hyaluronate (20 mg/ml), sodium chloride, sodium phosphate monobasic dihydrate, sodium phosphate bibasic dodecaidrate, water p.p.i.
Warnings
Indicated only for intra-arthic injections such as hip and knee and should be dispensed only by a doctor who received a specific training on the technique of intra-articular injections.
Before use check the integrity of the syringe and the expiry date. Do not use needles other than those indicated. The product must be injected in the presence of an infected or severely inflamed joint. Infiltration should be avoided in case of infections in place or inflammatory conditions of the skin near the infiltration site. Since clinical data on the use of hyaluronate in children are not available, treatment with Condonil IALQUATTRO in these cases is not recommended. It is recommended to recommend to the patient, after intra-articular injection, to avoid challenging physical activity for jointing and to resume normal activity after a couple of days.
Condronil IALQUATTRO is a disposable product, quality and sterility are guaranteed only if the syringe is sealed. Any residue must therefore be disposed of and not reused even after a new sterilization.
Do not use the product if the packaging is already open or damaged.
Keep out of reach of children.
The complete needle syringe must be eliminated immediately after use, although the solution has not been fully administered. After use delete according to the current rules.
Conservation
Store at 2-25 °C in a dry place in the original box. Protect from light, heat and frost.
Format
Pre-filled syringe containing 4 ml of apirogen gel, sterilized with wet heat.
